. 2015; 32(1): 43-50 | DOI: 10.4274/tjh.2013.0170 | |||
Sistemik Mastositozda Osteoporoz ve Osteopati BelirteçleriNilüfer Alpay Kanıtez1, Burak Erer1, Öner Doğan2, Nesimi Büyükbabanı2, Can Baykal3, Dilşad Sindel4, Refik Tanakol5, Akif Selim Yavuz61İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey2İstanbul University İstanbul Faculty of Medicine, Division of Pathology, İstanbul, Turkey 3İstanbul University İstanbul Faculty of Medicine, Division of Dermatology, İstanbul, Turkey 4İstanbul University İstanbul Faculty of Medicine, Division of Physical Treatment and Rehabilitation, İstanbul, Turkey 5İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology, İstanbul, Turkey 6İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey AMAÇ: Sistemik mastositozlu (SM) hastalarda osteoporoz, osteoskleroz ve litik kemik lezyonları görülebilir. Bu çalışmada nadir bir hastalık olan SM’de, kemik yoğunluk ölçümü (BMD), serumda kemik ‘turnover’ belirteçleri ve triptaz düzeyi araştırılmıştır. Osteoporosis and Osteopathy Markers in Patients with MastocytosisNilüfer Alpay Kanıtez1, Burak Erer1, Öner Doğan2, Nesimi Büyükbabanı2, Can Baykal3, Dilşad Sindel4, Refik Tanakol5, Akif Selim Yavuz61İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İstanbul, Turkey2İstanbul University İstanbul Faculty of Medicine, Division of Pathology, İstanbul, Turkey 3İstanbul University İstanbul Faculty of Medicine, Division of Dermatology, İstanbul, Turkey 4İstanbul University İstanbul Faculty of Medicine, Division of Physical Treatment and Rehabilitation, İstanbul, Turkey 5İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology, İstanbul, Turkey 6İstanbul University İstanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey OBJECTIVE: Osteoporosis, osteosclerosis, and lytic bone lesions have been observed in patients with systemic mastocytosis (SM). We examined bone mineral density (BMD) biochemical turnover markers and serum tryptase levels in SM, which is considered a rare disease. Nilüfer Alpay Kanıtez, Burak Erer, Öner Doğan, Nesimi Büyükbabanı, Can Baykal, Dilşad Sindel, Refik Tanakol, Akif Selim Yavuz. Osteoporosis and Osteopathy Markers in Patients with Mastocytosis. . 2015; 32(1): 43-50 Sorumlu Yazar: Nilüfer Alpay Kanıtez, Türkiye |
|